← All Stocks

MetLife, Inc.

MET · NYQ
$97.20+1.33%
52W Low: $67.3352W High: $100.93
Current: $97.20  ·  89% of 52-week range
Financial ServicesInsurance - LifeNYQ
View live charts, options flow & technicals for MetLife, Inc. → Open Dashboard

MetLife, Inc. (MET) is a financial services company in the insurance - life industry with $79.40B in trailing revenue trading at a 18.8× trailing P/E — analyst consensus: buy.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Key Statistics

Market Cap$61.77B
Revenue (TTM)$79.40B
EPS (TTM)$5.18
EPS (Fwd est.)$10.93
Employees46,000
Trailing P/E18.76
Forward P/E8.89
PEG Ratio0.51
Price / Sales0.78
Price / Book2.26
EV / EBITDA14.12
Beta (5Y)0.76

Analyst Consensus

Consensus
Buy
Analyst Price Target
+8.8% upside
Target: $105.75

Annual Revenue & Net Income

RevenueNet Income
'22
$67.41B
$5.28B
'23
$67.93B
$1.58B
'24
$70.13B
$4.43B
'25
$75.65B
$3.38B

Earnings History


QuarterActual EPSEstimateResult
Aug 2026
$2.43
$2.29Beat (+6.2%)
May 2026
$2.42
$2.27Beat (+6.7%)
Feb 2026
$2.49
$2.34Beat (+6.3%)
Nov 2025
$2.37
$2.32Beat (+2.2%)

Next Earnings Report

MetLife, Inc. is next expected to report earnings on 09 Nov 2026.

Profitability

24.0%
5.5%
4.6%
Gross
Margin
Operating
Margin
Net
Margin
Revenue Growth (YoY)10.5%
Return on Equity13.1%
Return on Assets0.5%

Balance Sheet

Cash & Equivalents$27.32B
Total Debt$50.31B
Net Position$22.99B (net debt)
Free Cash Flow (TTM)$-20.95B
Debt / Equity179.93

Share Ownership

Institutions 78.3%
Insiders 16.3%
Public 5.4%

Dividend

Annual Rate
$2.37
Yield
2.47%
Payout Ratio
44.0%
Ex-Dividend Date
04 Aug 2026
5Y Avg Yield
2.92%

Frequently Asked Questions

What does MetLife, Inc. (MET) do?
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, indiv…
What is MET's market cap?
MetLife, Inc. has a market capitalization of approximately $61.77B.
What is MET's P/E ratio?
MetLife, Inc. trades at a trailing P/E ratio of 18.8x and a forward P/E of 8.9x, which is below the broad market average of ~25x.
How much revenue does MET generate?
MetLife, Inc. generated $79.40B in trailing 12-month revenue.
What do analysts say about MET?
The analyst consensus rating for MetLife, Inc. is buy, with a mean price target of $105.75. That implies +8.8% upside from the current price.
When does MET report earnings?
MetLife, Inc. is next scheduled to report earnings on 09 Nov 2026.
Does MET pay a dividend?
Yes. MetLife, Inc. pays a dividend with a current yield of 2.47%, at an annual rate of $2.37 per share.

View live charts, options flow, gamma exposure, earnings history, and technical analysis for MetLife, Inc. on Apsis Markets.

Open Live Dashboard →